Jeffrey L. Ives, Ph.D. Dr. Ives has served as a member of our board of directors since May 2014. He is an Advisor to Access Biotechnology and a former Venture Partner at New Leaf Venture Partners. Dr. Ives also serves as a director on the board of Cara Therapeutics since 2014.
He currently also serves on the boards of several neurodegenerative disease companies including Pinteon Therapeutics, Orthogonal Neuroscience, and Astrocyte Pharmaceuticals. From 2008 until 2013, Dr. Ives served as the Chief Executive Officer of Satori Pharmaceuticals, Inc., a company focused on Alzheimer’s disease. Prior to Satori, he served as senior vice president at Pfizer, leading the neurodegenerative diseases, psychiatry and pain research areas. Dr. Ives received his doctorate and master’s degrees from Yale University and received his B.A. from Colgate University.